News and Media

News and Media

  • 2011 achievements and 2012 prospects

    January 26, 2012

  • BioAlliance Pharma reports its consolidated turnover for Q3 And announces progress for Loramyc® commercialization in Italy

    November 14, 2011

  • Consolidated accounts for the first semester of 2011 and recent significant key events

    September 21, 2011

  • Q2 2011: BioAlliance Pharma accelerates the progress of its “Orphan oncology products” portfolio and pursues its international partnerships on its “Specialty products”

    July 28, 2011

  • Q1 2011: achievement of key milestones in BioAlliance Pharma’s clinical development program

    May 13, 2011

  • Full-year financial results for 2010

    March 3, 2011

  • Consolidated turnover for 2010

    February 10, 2011

  • The structure of BioAlliance Pharma’s turnover for Q3 2010 reflects the dynamism of the company’s American and European collaborations

    October 21, 2010

  • Consolidated accounts for the first semester of 2010

    August 25, 2010

  • A record turnover for Q2 2010 reflecting the successful US FDA approval

    July 22, 2010

  • Q1 2010 reflects the new European partnership agreement with Therabel Expected recurrent revenues

    April 22, 2010

Press Release Signup

Subscribe to receive our Press Releases when they come out.

Presentations